AZN icon

AstraZeneca

1,137 hedge funds and large institutions have $33.8B invested in AstraZeneca in 2024 Q1 according to their latest regulatory filings, with 119 funds opening new positions, 485 increasing their positions, 340 reducing their positions, and 93 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more first-time investments, than exits

New positions opened: | Existing positions closed:

more call options, than puts

Call options by funds: $ | Put options by funds: $

more funds holding

Funds holding:

0.46% less ownership

Funds ownership: 32.57%32.11% (-0.46%)

1% less capital invested

Capital invested by funds: $34B → $33.8B (-$240M)

8% less funds holding in top 10

Funds holding in top 10: 1312 (-1)

Holders
1,137
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
12
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$480M
Puts
$470M
Net Calls
Net Calls Change

Top Sellers

1 -$903M
2 -$659M
3 -$157M
4
N
Nuveen
North Carolina
-$129M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$103M
Name Holding Trade Value Shares
Change
Change in
Stake
476
$960K
477
$958K
478
$954K
479
$953K
480
$951K
481
$950K
482
$945K
483
$938K
484
$931K
485
$925K
486
$921K
487
$916K
488
$913K
489
$912K
490
$908K
491
$907K
492
$900K
493
$899K
494
$898K
495
$895K
496
$893K
497
$893K
498
$892K
499
$887K
500
$883K